ArticleCancers2026
Therapeutic Targeting of miR-21 Restores SASH1 and Sensitizes HBV-HCC to Sorafenib.
Kyuyoung Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleCancers2026
Kyuyoung Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.